Key result
A brachial pulse pressure over 63 mmHg is associated with increased left ventricular mass and arterial stiffness, serving as a marker of established preclinical cardiovascular disease.
Why the study?
Is elevated brachial pulse pressure a marker of preclinical cardiovascular disease in patients with arterial hypertension?
Is elevated brachial pulse pressure a marker of preclinical cardiovascular disease in patients with arterial hypertension?
Elevated brachial pulse pressure (>63 mmHg) should be considered a marker of established preclinical cardiovascular disease rather than merely a risk factor for the development of arterial disease.
Answers are grounded in this paper and cite their sources.
Elevated brachial pulse pressure may mark preclinical disease in hypertension; hypothesis-generating and should not yet change practice.
Increasing attention has been focused on the pathophysiology and prognostic relevance of increased pulse pressure. High systolic pressure increases vascular load whereas low diastolic pressure reduces coronary perfusion pressure, both of which provide pathophysiological explanations for the prognostic value of pulse pressure. In a recent study we have demonstrated that in the presence of either normal or high peripheral resistance, brachial pulse pressure is associated with an increase in left ventricular mass and in arterial stiffness. As indicated in our study, a brachial pulse pressure over 63 mmHg represents a sign of established cardiovascular damage in the setting of arterial hypertension. Accordingly, we suggest elevated brachial pulse pressure should be considered a marker of established preclinical cardiovascular disease rather than a risk factor for the development of arterial disease.
No takes yet. Share an insight, caveat, or question.
Simone et al. (2006) conducted a review in Arterial hypertension. High brachial pulse pressure was evaluated on Left ventricular mass and arterial stiffness. A brachial pulse pressure over 63 mmHg is associated with increased left ventricular mass and arterial stiffness, serving as a marker of established preclinical cardiovascular disease.
Synapse has enriched 10 related papers. Consider them for comparative context: